Hans Biomed Corp. (042520)
Market Open
11 Aug, 06:30
KRX SM KRX SM Primary ₩
23,800. 00
+400
+1.7094%
₩
405.17B Market Cap
- P/E Ratio
240% Div Yield
11,946 Volume
- Eps
₩ 23,400
Previous Close Want to track 042520 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
042520 trading today higher at ₩23,800, an increase of 1.7094% from yesterday's close, completing a monthly increase of 3.9301% or ₩900. Over the past 12 months, 042520 stock lost -13.1387%.
042520 pays dividends to its shareholders, with the most recent payment made on Oct 05, 2020.
The stock of the company had never split.
The company's stock is traded on one exchange.
Hans Biomed Corp. (042520) FAQ
What is the stock price today?
The current price is ₩23,800.00.
On which exchange is it traded?
Hans Biomed Corp. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 042520.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 240%.
What is its market cap?
As of today, the market cap is 405.17B.
Has Hans Biomed Corp. ever had a stock split?
No, there has never been a stock split.
Hans Biomed Corp. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 297 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
HansBiomed Corporation, alongside its subsidiaries, dedicates itself to the research, development, production, and sale of medical materials designed for various procedures as well as the raw materials for medical supplies. Originally known as Hans Medical Corp., the company underwent a name change to HansBiomed Corporation in June 2000. Founded in 1990, HansBiomed has established its headquarters in Seoul, South Korea, positioning itself as a pivotal player in the field of medical materials and solutions. Through its commitment to innovation and quality, the company aims to contribute significantly to advancements in medical care and treatment options.
Products and Services
- ExFuse: A demineralized bone matrix combined with cancellous bone in gel/putty form, designed to facilitate bone regeneration.
- BellaFuse: Another form of demineralized bone matrix intended for similar applications as ExFuse, emphasizing ease of use.
- Genesis: A cancellous sponge block/filler that aids in the process of bone healing and regeneration.
- Pedi-Stick: A specialized demineralized cortical bone stick, tailored for specific surgical requirements.
- SureChip: Comprising cancellous bone chips, this product is utilized in various medical procedures to aid in bone repair.
- OsteoGrow: This demineralized bone matrix inserter simplifies the application process, enhancing the efficiency and effectiveness of bone matrix usage.
- BellaCell HD: An allograft dermal product specifically designed for patients who have suffered skin loss due to breast cancer, facilitating the process of skin transplantation and recovery.
- SureDerm: An acellular dermal matrix that plays a crucial role in various reconstructive surgeries, promoting tissue integration and regeneration.
- BELLAGEL: A breast prosthesis solution offering an internal, gel-filled option for individuals seeking breast reconstruction or augmentation.
- MINT Lift: A Polydioxanone (PDO) thread designed for minimally invasive face lifting procedures, promoting skin tightening and rejuvenation.
- EZ-Tcon solution: A solution aimed at enhancing tissue connectivity and support in various medical procedures.
- Lion HT/HN: A hair transplanter tool that includes both the body and needle components, intended for precise and effective hair transplantation.
- Scar Clinic: A comprehensive scar management solution, designed to reduce the appearance of scars and improve skin texture following surgery or injury.
Contact Information
Address: 7, Jeongui-ro 8-gil
Phone: 82 2 466 2266
Website: https://www.hansbiomed.com
